Skip to main content

Want a detailed portfolio tracker?

Ascentage Pharma Group International (AAPG) P/E (2025 - 2026)

Ascentage Pharma Group International (AAPG) P/E from Jan 24, 2025 to Jul 21, 2026. The TTM Ascentage Pharma Group International (AAPG) P/E is -4.81. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ascentage Pharma Group International (AAPG)

YearP/EChange
2026-4.81-27.53%
2025-6.64N/A

Comparison Ascentage Pharma Group International (AAPG) P/E with competitors

Ascentage Pharma Group International (AAPG) P/E is -4.81.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.09%
ENLVEnlivex Ltd0.07-101.55%
FGENFibroGen Inc0.24-104.99%
CHRSCoherus Biosciences Inc0.85-117.64%
FBIOFortress Biotech Inc0.95-119.73%
ORMPOramed Pharmaceuticals Inc1.50-131.24%
AGENAgenus Inc3.01-162.56%
INVAInnoviva Inc3.15-165.56%
VXRTVaxart Inc3.55-173.79%
CRMDCorMedix Inc3.63-175.42%
CVACCureVac N.V.4.45-192.41%
GLPGGalapagos NV4.86-201.00%
SRPTSarepta Therapeutics Inc4.88-201.48%
ABEOAbeona Therapeutics Inc5.39-211.99%
ABUSArbutus Biopharma Corp5.60-216.31%
ZVRAZevra Therapeutics Inc5.89-222.37%
SPROSpero Therapeutics Inc6.23-229.47%
CGENCompugen Ltd6.31-231.24%
RIGLRigel Pharmaceuticals6.87-242.85%
SLXNSilexion Therapeutics Corp7.30-251.66%
OMEROmeros Corporation9.26-292.46%
AUPHAurinia Pharmaceuticals Inc9.58-299.24%
PLXProtalix BioTherapeutics Inc10.89-326.38%
ACADAcadia Pharmaceuticals Inc11.73-343.79%
TBPHTheravance Biopharma Inc12.26-354.89%
ADMAAdma Biologics Inc12.42-358.13%
HRMYHarmony Biosciences Holdings Inc13.82-387.27%
SABSSAB Biotherapeutics Inc14.14-393.84%
NAGENiagen Bioscience Inc14.82-408.02%
INCYIncyte Corp15.82-428.89%
REGNRegeneron Pharmaceuticals Inc15.86-429.60%
PBYIPuma Biotechnology Inc17.32-459.93%
CPRXCatalyst Pharmaceuticals Inc17.44-462.50%
EXELExelixis Inc17.54-464.55%
TGTXTG Therapeutics Inc18.97-494.24%
MDXGMimedx Group Inc20.55-527.21%
XOMAXOMA Royalty Corp22.87-575.50%
ARGXArgen X SE24.30-605.08%
CTMXCytomX Therapeutics Inc24.82-615.96%
XOMAOXOMA Royalty Corp25.34-626.84%
HALOHalozyme Therapeutics Inc25.62-632.64%
XOMAPXOMA Royalty Corp25.67-633.60%
VRTXVertex Pharmaceuticals Inc27.99-681.93%
RPRXRoyalty Pharma plc - Class A28.69-696.33%
SLNOSoleno Therapeutics Inc29.02-703.14%
ASNDAscendis Pharma A/S30.09-725.39%
LGNDLigand Pharmaceuticals Inc - Class B37.91-888.08%
APLSApellis Pharmaceuticals Inc39.02-911.13%
BMRNBiomarin Pharmaceutical Inc42.21-977.46%
KRYSKrystal Biotech Inc45.34-1042.56%
ONCBeiGene Ltd69.54-1545.54%
PHARPharming Group N.V.75.03-1659.56%
TECHBio-Techne Corp101.96-2219.41%
VCELVericel Corp109.92-2384.94%
ALNYAlnylam Pharmaceuticals Inc117.96-2552.14%
GMABGenmab140.29-3016.23%
TLXTelix Pharmaceuticals Ltd162.15-3470.67%
CORTCorcept Therapeutics Inc212.86-4524.67%